Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;32(4):446-470.
doi: 10.1111/vec.13227.

2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics

Claire R Sharp  1 , Marie-Claude Blais  2 , Corrin J Boyd  1 , Benjamin M Brainard  3 , Daniel L Chan  4 , Armelle de Laforcade  5 , Robert Goggs  6 , Julien Guillaumin  7 , Alex Lynch  8 , Erin Mays  9 , Duana McBride  10 , Tommaso Rosati  11 , Elizabeth A Rozanski  5
Affiliations

2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics

Claire R Sharp et al. J Vet Emerg Crit Care (San Antonio). 2022 Jul.

Abstract

Objectives: To systematically review available evidence and establish guidelines related to the use of thrombolytics for the management of small animals with suspected or confirmed thrombosis.

Design: PICO (Population, Intervention, Control, and Outcome) questions were formulated, and worksheets completed as part of a standardized and systematic literature evaluation. The population of interest included dogs and cats (considered separately) and arterial and venous thrombosis. The interventions assessed were the use of thrombolytics, compared to no thrombolytics, with or without anticoagulants or antiplatelet agents. Specific protocols for recombinant tissue plasminogen activator were also evaluated. Outcomes assessed included efficacy and safety. Relevant articles were categorized according to level of evidence, quality, and as to whether they supported, were neutral to, or opposed the PICO questions. Conclusions from the PICO worksheets were used to draft guidelines, which were subsequently refined via Delphi surveys undertaken by the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) working group.

Results: Fourteen PICO questions were developed, generating 14 guidelines. The majority of the literature addressing the PICO questions in dogs is experimental studies (level of evidence 3), thus providing insufficient evidence to determine if thrombolysis improves patient-centered outcomes. In cats, literature was more limited and often neutral to the PICO questions, precluding strong evidence-based recommendations for thrombolytic use. Rather, for both species, suggestions are made regarding considerations for when thrombolytic drugs may be considered, the combination of thrombolytics with anticoagulant or antiplatelet drugs, and the choice of thrombolytic agent.

Conclusions: Substantial additional research is needed to address the role of thrombolytics for the treatment of arterial and venous thrombosis in dogs and cats. Clinical trials with patient-centered outcomes will be most valuable for addressing knowledge gaps in the field.

Keywords: anticoagulant; antiplatelet agent; cats; dogs; thrombosis.

PubMed Disclaimer

Conflict of interest statement

Benjamin M. Brainard and Daniel L. Chan are editors of the Journal. The authors declare no other conflict of interest.

References

    1. Thompson MF, Scott‐Moncrieff CS, Hogan DF. Thrombolytic therapy in dogs and cats. J Vet Emerg Crit Care. 2001;11(2):111‐121.
    1. Adivitiya KYP. The evolution of recombinant thrombolytics: current status and future directions. Bioengineered. 2017;8(4):331‐358. - PMC - PubMed
    1. Verstraete M. Third‐generation thrombolytic drugs. Am J Med. 2000;109(1):52‐58. - PubMed
    1. Klegerman ME. Translational initiatives in thrombolytic therapy. Front Med. 2017;11(1):1‐19. - PubMed
    1. Goggs R, Blais MC, Brainard BM, et al. American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: small animal. J Vet Emerg Crit Care. 2019;29(1):12‐36. - PubMed